पहचान

Risperidone Impurity 47

सूचीबद्ध नहीं · C23H29FN4O3

01पहचान

Lazychem IDLC-47905
CAS RNसूचीबद्ध नहीं
PubChem CID9910449
Molecular formulaC23H29FN4O3
Molecular weight428.5 g/mol
IUPAC name3-[2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl]-9-hydroxy-2-methyl-2,3,6,7,8,9-hexahydropyrido[1,2-a]pyrimidin-4-one
InChIKeyKZYCUMMUAIJCRI-UHFFFAOYSA-N

02संरचना और त्रिविम रसायन

2D structurePubChem CID 9910449
Two-dimensional chemical structure of Risperidone Impurity 47
Two-dimensional structure for the PubChem identity linked to this record. Confirm the identifiers before analytical use.

The parsed structure contains 5 rings, includes aromatic atoms, includes aliphatic carbon, contains at least one halogen atom. These statements are calculated from the published structure string.

Defined stereocentres0
Ring count5
Secondary amines0
Tertiary amines1
SMILESCC1C(C(=O)N2CCCC(C2=N1)O)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F
InChIसूचीबद्ध नहीं

03Stereochemistry

The published structure contains 0 defined and 3 unassigned tetrahedral stereocentres. The exact wedge and dash depiction is shown above.

Defined centres0Structure assigned
Unassigned centres3Structure unspecified
Assignment statusUnassignedExact published identity
Tetrahedral upper bound≤ 8Before symmetry reduction

Published same-connectivity configurations

1 record

These records have the same connectivity, molecular formula and protonation layer, but a different complete InChIKey stereochemical layer. Only separately structure-linked records are shown.

No additional structure-linked configuration with the same connectivity is currently present in the LazyChem dataset.

Scope: The mathematical 2^n value is only an upper bound. Symmetry and other stereogenic elements can change the number of distinct stereoisomers. A hypothetical configuration is not published as a compound record without a verified structure identity.

04भारत में स्थिति

Exact-compound status is evaluated only against the published name and CAS number. Confirm the current official instrument before a regulatory decision.

05नाम और संबंध

API और मूल औषधि

सूचीबद्ध नहीं

नाम और संबंध

    अशुद्धियाँ और संबंधित यौगिक

      06स्रोत